Zhuoli Sun

Tetrahydropyridin-4-ylpicolinoylglycines as novel and orally active prolyl hydroxylase 2 (PHD2) inhibitors for the treatment of renal anemia.

Mingxuan Mao, Xiaojin Zhang, Zhihong Li, 2022, European journal of medicinal chemistry.